RxDoctor Payments DataLook up a doctor →

Gary Richmond

Pulmonary Disease · Fort Lauderdale, FLNPI 1255345963

Payments from drug & device makers

$2,117,950in general payments, 2019–2025

Across 393 payments — averaging $5389.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$1.4M
  • Gilead$679K
  • Insmed, Inc.$14K
  • GSK$8K
  • Merck$7K
  • Theratechnologies Inc.$3K
  • plus $858 from 12 others
$218,523in research payments, 2019–2025

Across 39 payments — averaging $5603.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Theratechnologies Inc.$217K
  • Gilead$2K

What the payments were for

  • Consulting fees$8,56071%
  • Travel & lodging$1,0619%
  • Food & beverage$1,92716%
  • Education$4704%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,117,950 in reported general payments places this provider in the 95th percentile of 953 pulmonary disease providers in Florida.

See all pulmonary disease providers in Florida

Other pulmonary disease in Fort Lauderdale

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →